Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedOnly a minor revision/version update is shown (Revision: v3.3.2) in the page footer; no core content or study details appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page footer now shows Revision: v3.3.1 instead of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics to the study page. Removed a banner about government funding status and NIH operations.SummaryDifference0.6%

- Check36 days agoChange DetectedThe MedlinePlus related topics section no longer lists 'Ovarian Cancer' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page underwent a visual/UI refresh with a new header and updated formatting; no core content such as study title, NCT number, eligibility criteria, or outcomes changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a government funding notice and operating status guidance, plus a pointer to cc.nih.gov; - Bumped version from v3.1.0 to v3.2.0.SummaryDifference6%

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.